Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: A paradigm for molecular subtyping of urothelial cell carcinoma of the bladder

Rosalyn M. Adam, David Degraff

Research output: Contribution to journalReview article

9 Citations (Scopus)

Abstract

Background: Recent molecular characterization studies focusing on bladder cancer have provided a wealth of information, including the identification of specific molecular subtypes of this disease. Interestingly, a particular molecular subtype identified by several different groups is characterized, at least in part, by the presence of squamous differentiation (SqD) in a significant fraction of primary tumors. Tumors that exhibit SqD are extremely aggressive. Moreover, conflicting reports exist relative to the sensitivity of bladder tumors exhibiting SqD to multimodal treatment. Bladder cancers that exhibit SqD appear to be distinct clinical entities and are often associated with a specific molecular subtype; therefore, it is important to understand the molecular drivers of this process. Purpose: Because presence of SqD is closely associated with a basal molecular phenotype, we review the evidence for specific pathways in SqD. In addition, we pose key areas for future exploration.

Original languageEnglish (US)
Pages (from-to)444-450
Number of pages7
JournalUrologic Oncology: Seminars and Original Investigations
Volume33
Issue number10
DOIs
StatePublished - Oct 1 2015

Fingerprint

Urinary Bladder Neoplasms
Urinary Bladder
Carcinoma
Combined Modality Therapy
Neoplasms
Phenotype

All Science Journal Classification (ASJC) codes

  • Oncology
  • Urology

Cite this

@article{56eb2e5dff714f16a3047d48e97eabd3,
title = "Molecular mechanisms of squamous differentiation in urothelial cell carcinoma: A paradigm for molecular subtyping of urothelial cell carcinoma of the bladder",
abstract = "Background: Recent molecular characterization studies focusing on bladder cancer have provided a wealth of information, including the identification of specific molecular subtypes of this disease. Interestingly, a particular molecular subtype identified by several different groups is characterized, at least in part, by the presence of squamous differentiation (SqD) in a significant fraction of primary tumors. Tumors that exhibit SqD are extremely aggressive. Moreover, conflicting reports exist relative to the sensitivity of bladder tumors exhibiting SqD to multimodal treatment. Bladder cancers that exhibit SqD appear to be distinct clinical entities and are often associated with a specific molecular subtype; therefore, it is important to understand the molecular drivers of this process. Purpose: Because presence of SqD is closely associated with a basal molecular phenotype, we review the evidence for specific pathways in SqD. In addition, we pose key areas for future exploration.",
author = "Adam, {Rosalyn M.} and David Degraff",
year = "2015",
month = "10",
day = "1",
doi = "10.1016/j.urolonc.2015.06.006",
language = "English (US)",
volume = "33",
pages = "444--450",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Molecular mechanisms of squamous differentiation in urothelial cell carcinoma

T2 - A paradigm for molecular subtyping of urothelial cell carcinoma of the bladder

AU - Adam, Rosalyn M.

AU - Degraff, David

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Background: Recent molecular characterization studies focusing on bladder cancer have provided a wealth of information, including the identification of specific molecular subtypes of this disease. Interestingly, a particular molecular subtype identified by several different groups is characterized, at least in part, by the presence of squamous differentiation (SqD) in a significant fraction of primary tumors. Tumors that exhibit SqD are extremely aggressive. Moreover, conflicting reports exist relative to the sensitivity of bladder tumors exhibiting SqD to multimodal treatment. Bladder cancers that exhibit SqD appear to be distinct clinical entities and are often associated with a specific molecular subtype; therefore, it is important to understand the molecular drivers of this process. Purpose: Because presence of SqD is closely associated with a basal molecular phenotype, we review the evidence for specific pathways in SqD. In addition, we pose key areas for future exploration.

AB - Background: Recent molecular characterization studies focusing on bladder cancer have provided a wealth of information, including the identification of specific molecular subtypes of this disease. Interestingly, a particular molecular subtype identified by several different groups is characterized, at least in part, by the presence of squamous differentiation (SqD) in a significant fraction of primary tumors. Tumors that exhibit SqD are extremely aggressive. Moreover, conflicting reports exist relative to the sensitivity of bladder tumors exhibiting SqD to multimodal treatment. Bladder cancers that exhibit SqD appear to be distinct clinical entities and are often associated with a specific molecular subtype; therefore, it is important to understand the molecular drivers of this process. Purpose: Because presence of SqD is closely associated with a basal molecular phenotype, we review the evidence for specific pathways in SqD. In addition, we pose key areas for future exploration.

UR - http://www.scopus.com/inward/record.url?scp=84942192478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942192478&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2015.06.006

DO - 10.1016/j.urolonc.2015.06.006

M3 - Review article

C2 - 26254697

AN - SCOPUS:84942192478

VL - 33

SP - 444

EP - 450

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 10

ER -